Leukemia, mast-cell

Search Trials
A Study to Evaluate the Efficacy and Safety of Maralixibat in Subjects With Progressive Familial Intrahepatic Cholestasis (MARCH-PFIC)
Status:
Recruiting
Last Changed:
Aug 7, 2019
First Changed:
Apr 5, 2019
Disease(s):
Progressive Familial Intrahepatic Cholestasis (PFIC)
Intervention(s):
MaralixibatPlacebo
A Placebo-controlled Study of Maralixibat (SHP625) in Pediatric Subjects With Progressive Familial Intrahepatic Cholestasis (PFIC)
Status:
Withdrawn
Last Changed:
Mar 18, 2019
First Changed:
Nov 27, 2017
Disease(s):
Progressive Familial Intrahepatic Cholestasis (PFIC)
Intervention(s):
MaralixibatPlacebo
Second-line Therapy of Unresectable Cholangiocarcinoma by RADIOEMBOLIZATION
Status:
Terminated
Last Changed:
Aug 7, 2013
First Changed:
Jun 28, 2011
Disease(s):
Cholestasis, Progressive Familial Intrahepatic 3
Intervention(s):
Yttrium microsphere injection
Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer
Status:
Completed
Last Changed:
May 30, 2017
First Changed:
Jul 11, 2005
Disease(s):
Acute Undifferentiated Leukemia
Intervention(s):
alemtuzumabtotal-body irradiationfludarabine phosphatecyclosporinemycophenolate mofetilallogeneic hematopoietic stem cell transplantationperipheral blood stem cell transplantationgraft versus host disease prophylaxis/therapylaboratory biomarker analysis
Sunitinib in Treating Patients With Idiopathic Myelofibrosis
Status:
Terminated
Last Changed:
May 28, 2014
First Changed:
Oct 13, 2006
Disease(s):
Accelerated Phase Chronic Myelogenous Leukemia
Intervention(s):
sunitinib malate

Connect. Empower. Inspire.